Product References
TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.
Human mutation
van der Zee J,Gijselinck I,Van Mossevelde S,Perrone F,Dillen L,Heeman B,Bäumer V,Engelborghs S,De Bleecker J,Baets J,Gelpi E,Rojas-García R,Clarimón J,Lleó A,Diehl-Schmid J,Alexopoulos P,Perneczky R,Synofzik M,Just J,Schöls L,Graff C,Thonberg H,Borroni B,Padovani A,Jordanova A,Sarafov S,Tournev I,de Mendonça A,Miltenberger-Miltényi G,Simões do Couto F,Ramirez A,Jessen F,Heneka MT,Gómez-Tortosa E,Danek A,Cras P,Vandenberghe R,De Jonghe P,De Deyn PP,Sleegers K,Cruts M,Van Broeckhoven C,Goeman J,Nuytten D,Smets K,Robberecht W,Damme PV,Bleecker J,Santens P,Dermaut B,Versijpt J,Michotte A,Ivanoiu A,Deryck O,Bergmans B,Delbeck J,Bruyland M,Willems C,Salmon E,Pastor P,Ortega-Cubero S,Benussi L,Ghidoni R,Binetti G,Hernández I,Boada M,Ruiz A,Sorbi S,Nacmias B,Bagnoli S,Sorbi S,Sanchez-Valle R,Llado A,Santana I,Rosário Almeida M,Frisoni GB,Maetzler W,Matej R,Fraidakis MJ,Kovacs GG,Fabrizi GM,Testi S
323600 was used in immunohistochemistry - paraffin section to examine the mutation spectrum of the TANK-Binding Kinase 1 gene and its associated phenotypic spectrum in patients with FTD, ALS or FTD plus ALS
Wed Mar 01 00:00:00 EST 2017
Neuropathological criteria of anti-IgLON5-related tauopathy.
Acta neuropathologica
Gelpi E,Höftberger R,Graus F,Ling H,Holton JL,Dawson T,Popovic M,Pretnar-Oblak J,Högl B,Schmutzhard E,Poewe W,Ricken G,Santamaria J,Dalmau J,Budka H,Revesz T,Kovacs GG
323600 was used in immunohistochemistry - paraffin section to detail the neuropathological features of the anti-IgLON5 syndrome in order to diagnose patients
Sat Oct 01 00:00:00 EDT 2016
An autopsy case of neuronal intermediate filament inclusion disease with regard to immunophenotypic and topographical analysis of the neuronal inclusions.
Neuropathology : official journal of the Japanese Society of Neuropathology
Inoue K,Fujimura H,Ueda K,Matsumura T,Itoh K,Sakoda S
32-3600 was used in immunohistochemistry - paraffin section to report an autopsy case of neuronal intermediate filament inclusion disease.
Tue Dec 01 00:00:00 EST 2015
PRKAR1B mutation associated with a new neurodegenerative disorder with unique pathology.
Brain : a journal of neurology
Wong TH,Chiu WZ,Breedveld GJ,Li KW,Verkerk AJ,Hondius D,Hukema RK,Seelaar H,Frick P,Severijnen LA,Lammers GJ,Lebbink JH,van Duinen SG,Kamphorst W,Rozemuller AJ,Bakker EB,Neumann M,Willemsen R,Bonifati V,Smit AB,van Swieten J
32-3600 was used in western blot to study the association of PRKAR1B mutation with a new neurodegenerative disorder
Thu May 01 00:00:00 EDT 2014
Frontotemporal dementia-amyotrophic lateral sclerosis syndrome locus on chromosome 16p12.1-q12.2: genetic, clinical and neuropathological analysis.
Acta neuropathologica
Dobson-Stone C,Luty AA,Thompson EM,Blumbergs P,Brooks WS,Short CL,Field CD,Panegyres PK,Hecker J,Solski JA,Blair IP,Fullerton JM,Halliday GM,Schofield PR,Kwok JB
32-3600 was used in Immunohistochemistry to suggest that a locus on chromosome 16p12.1-16q12.2 is responsible for an unusual cluster of neurodegenerative phenotypes.
Mon Apr 01 00:00:00 EDT 2013
Gliosarcoma with ependymal and PNET-like differentiation.
Clinical neuropathology
Shintaku M,Yoneda H,Hirato J,Nagaishi M,Okabe H
32-3600 was used in immunohistochemistry to characterize a rare case of gliosarcoma
Thu Mar 13 00:00:00 EDT 2014
An MND/ALS phenotype associated with C9orf72 repeat expansion: abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline.
Neuropathology : official journal of the Japanese Society of Neuropathology
Troakes C,Maekawa S,Wijesekera L,Rogelj B,Siklós L,Bell C,Smith B,Newhouse S,Vance C,Johnson L,Hortobágyi T,Shatunov A,Al-Chalabi A,Leigh N,Shaw CE,King A,Al-Sarraj S
32-3600 was used in immunohistochemistry - paraffin section to study 4 cases of chromosome 9-linked motor neuron disease/amyotrophic lateral sclerosis.
Mon Oct 01 00:00:00 EDT 2012
FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.
Brain : a journal of neurology
Neumann M,Bentmann E,Dormann D,Jawaid A,DeJesus-Hernandez M,Ansorge O,Roeber S,Kretzschmar HA,Munoz DG,Kusaka H,Yokota O,Ang LC,Bilbao J,Rademakers R,Haass C,Mackenzie IR
Thu Sep 01 00:00:00 EDT 2011
FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.
Brain : a journal of neurology
Neumann M,Bentmann E,Dormann D,Jawaid A,DeJesus-Hernandez M,Ansorge O,Roeber S,Kretzschmar HA,Munoz DG,Kusaka H,Yokota O,Ang LC,Bilbao J,Rademakers R,Haass C,Mackenzie IR
Thu Sep 01 00:00:00 EDT 2011
What's in a name? Neuronal intermediate filament inclusion disease (NIFID), frontotemporal lobar degeneration-intermediate filament (FTLD-IF) or frontotemporal lobar degeneration-fused in sarcoma (FTLD-FUS)?
Journal of neurology, neurosurgery, and psychiatry
Menon R,Baborie A,Jaros E,Mann DM,Ray PS,Larner AJ
Thu Dec 01 00:00:00 EST 2011
Cytoskeletal organization of the developing mouse olfactory nerve layer.
The Journal of comparative neurology
Akins MR,Greer CA
32-3600 was used in immunohistochemistry to test if the cytoskeletal elements of olfactory sensory neuron axons may be are differentially expressed across the olfactory nerve layer.
Tue Jan 10 00:00:00 EST 2006
Cytoskeletal organization of the developing mouse olfactory nerve layer.
The Journal of comparative neurology
Akins MR,Greer CA
32-3600 was used in immunohistochemistry to test if the cytoskeletal elements of olfactory sensory neuron axons may be are differentially expressed across the olfactory nerve layer.
Tue Jan 10 00:00:00 EST 2006